Novant Health Activates Sites for COVID-19 Anti-Viral Study in Record Time: Can Leronlimab Help SARS-CoV-2 Patients?

Novant Health will be one of the first clinical investigational sites to study whether a medication called leronlimab could be used to treat SARS-CoV-2, the virus behind the COVID-19 pandemic. Previously, leronlimab has been used in combination with medications to...

Leronlimab Shows Inhibits Colon Carcinoma Metastases to Liver & Lung in Preclinical Studies: Can the Sponsor Finance Clinicals?

CytoDyn’s PRO 140, a CCR5 antagonist called leronlimab, inhibited a human colon carcinoma cell line, SW480, metastases to liver and lung in a well-accepted mouse model in pre-clinical research phase. Cytodyn, a small emerging biotech, was recently cleared by the FDA...

Pin It on Pinterest